Variant report
Variant | rs3129046 |
---|---|
Chromosome Location | chr6:29670652-29670653 |
allele | C/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:29670114..29670993-chr6:29802276..29803394,5 | K562 | blood: |
No data |
No data |
No data |
No data |
rs_ID | r2[population] |
---|---|
rs1419696 | 0.83[EUR][1000 genomes] |
rs1610588 | 0.89[AFR][1000 genomes];0.91[AMR][1000 genomes];0.96[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs1610742 | 0.89[AFR][1000 genomes];0.91[AMR][1000 genomes];0.96[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs1610744 | 0.89[AFR][1000 genomes];0.91[AMR][1000 genomes];0.96[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs1628578 | 0.83[EUR][1000 genomes] |
rs1632957 | 0.85[EUR][1000 genomes] |
rs1632960 | 0.86[EUR][1000 genomes] |
rs1633106 | 0.84[EUR][1000 genomes] |
rs1633107 | 0.83[EUR][1000 genomes] |
rs2107203 | 0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs2158290 | 0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs2517911 | 0.86[EUR][1000 genomes] |
rs2535238 | 0.81[ASN][1000 genomes] |
rs2535274 | 0.93[ASN][1000 genomes] |
rs2535275 | 0.93[ASN][1000 genomes] |
rs2747421 | 0.81[ASN][1000 genomes] |
rs2747427 | 0.81[ASN][1000 genomes] |
rs2747428 | 0.81[ASN][1000 genomes] |
rs2747429 | 0.81[ASN][1000 genomes] |
rs2747457 | 0.85[ASN][1000 genomes] |
rs2747460 | 0.93[ASN][1000 genomes] |
rs2907897 | 0.93[ASN][1000 genomes] |
rs3094579 | 0.81[ASN][1000 genomes] |
rs3094724 | 0.87[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs3094725 | 0.89[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs3094729 | 0.86[ASN][1000 genomes] |
rs3094730 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs3094731 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs3094732 | 0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs3094734 | 0.85[AMR][1000 genomes];0.87[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs3095284 | 0.84[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs3116799 | 1.00[AFR][1000 genomes];0.96[AMR][1000 genomes];0.93[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs3116800 | 0.81[AMR][1000 genomes];0.82[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs3116802 | 0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs3116803 | 0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs3116804 | 0.85[AMR][1000 genomes];0.87[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs3116811 | 0.87[ASN][1000 genomes] |
rs3116814 | 0.95[ASN][1000 genomes] |
rs3117295 | 0.84[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs3117299 | 0.84[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs3117301 | 0.93[ASN][1000 genomes] |
rs3117312 | 0.84[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs3129033 | 0.95[ASN][1000 genomes] |
rs3129035 | 0.95[ASN][1000 genomes] |
rs3129036 | 0.84[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs3129037 | 0.82[AMR][1000 genomes];0.80[EUR][1000 genomes];0.84[ASN][1000 genomes] |
rs3129039 | 0.86[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs3129042 | 0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs3129047 | 0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs3129048 | 0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs3129055 | 0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs3129056 | 0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs3129058 | 0.82[ASN][1000 genomes] |
rs3129061 | 0.85[AMR][1000 genomes];0.87[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs3129062 | 0.81[ASN][1000 genomes] |
rs3129063 | 0.82[ASN][1000 genomes] |
rs3129065 | 0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs3129066 | 0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs3129067 | 0.85[AMR][1000 genomes];0.87[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs3129070 | 0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs3129072 | 0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs3129082 | 0.86[ASN][1000 genomes] |
rs3129084 | 0.87[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs3129086 | 0.87[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs3129092 | 0.87[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs3129189 | 0.82[ASN][1000 genomes] |
rs3131864 | 0.89[AFR][1000 genomes];0.93[AMR][1000 genomes];0.98[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs3131865 | 0.83[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs3131866 | 0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs3131867 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs3131868 | 0.85[AMR][1000 genomes];0.87[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs3131870 | 0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs3131871 | 0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs3131872 | 0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs3131873 | 0.84[AMR][1000 genomes];0.88[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs3131874 | 0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs3131884 | 0.80[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs3131889 | 0.81[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs3131890 | 0.88[ASN][1000 genomes] |
rs3131895 | 0.85[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs3131898 | 0.80[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs374317 | 0.81[ASN][1000 genomes] |
rs375984 | 0.81[ASN][1000 genomes] |
rs376319 | 0.81[ASN][1000 genomes] |
rs387640 | 0.81[ASN][1000 genomes] |
rs387642 | 0.81[ASN][1000 genomes] |
rs417764 | 0.81[ASN][1000 genomes] |
rs448489 | 0.81[ASN][1000 genomes] |
rs9258017 | 0.86[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs9258048 | 0.85[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs9258052 | 0.80[ASN][1000 genomes] |
rs9258068 | 1.00[AFR][1000 genomes];0.95[AMR][1000 genomes];0.97[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs9258074 | 0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs9258077 | 0.89[AFR][1000 genomes];0.93[AMR][1000 genomes];0.84[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs9258078 | 0.85[AMR][1000 genomes];0.87[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs9258079 | 0.85[AMR][1000 genomes];0.87[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs9258083 | 0.85[AMR][1000 genomes];0.87[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs9258087 | 0.86[AMR][1000 genomes];0.87[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs9258088 | 0.84[AMR][1000 genomes];0.87[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs9258103 | 0.81[AMR][1000 genomes];0.81[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs9258104 | 0.84[AMR][1000 genomes];0.82[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs9258107 | 0.83[ASN][1000 genomes] |
rs9258108 | 0.83[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | esv2758039 | chr6:29469101-29672665 | Flanking Active TSS Active TSS Strong transcription Enhancers Weak transcription Bivalent Enhancer Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 23 gene(s) | inside rSNPs | diseases |
2 | esv2759411 | chr6:29469101-29672665 | Active TSS Enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Strong transcription Bivalent Enhancer Genic enhancers Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 23 gene(s) | inside rSNPs | diseases |
3 | nsv883530 | chr6:29645038-29677641 | Weak transcription Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 5 gene(s) | inside rSNPs | diseases |
4 | esv20940 | chr6:29653954-29923410 | Flanking Active TSS Strong transcription Flanking Bivalent TSS/Enh Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Genic enhancers Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 46 gene(s) | inside rSNPs | diseases |
5 | nsv970675 | chr6:29657036-29692268 | Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription Transcr. at gene 5' and 3' Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 8 gene(s) | inside rSNPs | diseases |
6 | nsv428475 | chr6:29659525-29763392 | Strong transcription Weak transcription Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 27 gene(s) | inside rSNPs | diseases |
7 | nsv428139 | chr6:29659525-29892317 | Bivalent Enhancer Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Weak transcription Strong transcription Flanking Bivalent TSS/Enh Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 41 gene(s) | inside rSNPs | diseases |
8 | nsv427749 | chr6:29659525-29975144 | Enhancers Active TSS Strong transcription Flanking Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 53 gene(s) | inside rSNPs | diseases |
9 | nsv508397 | chr6:29663132-29761448 | Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Strong transcription Transcr. at gene 5' and 3' Enhancers Bivalent/Poised TSS Bivalent Enhancer Genic enhancers ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 26 gene(s) | inside rSNPs | diseases |
10 | nsv519888 | chr6:29668537-29673483 | Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh | Chromatin interactive region | n/a | inside rSNPs | diseases |
SNP | Gene | Cis/trans | Tissue | Source |
---|---|---|---|---|
rs3129046 | ZNF323 | cis | parietal | SCAN |
rs3129046 | HIST1H2BM | cis | cerebellum | SCAN |
rs3129046 | HLA-A | cis | multi-tissue | Pritchard |
rs3129046 | BTN3A2 | cis | multi-tissue | Pritchard |
rs3129046 | KIT | trans | multi-tissue | Pritchard |
rs3129046 | HLA-A | trans | brain | seeQTL |
rs3129046 | HIST1H3I | cis | cerebellum | SCAN |
rs3129046 | ZKSCAN3 | cis | parietal | SCAN |
rs3129046 | HLA-A | cis | brain | seeQTL |
rs3129046 | ZFP57 | cis | lymphoblastoid | seeQTL |
rs3129046 | ZFP57 | cis | multi-tissue | Pritchard |
rs3129046 | HLA-A | cis | lymphoblastoid | seeQTL |
rs3129046 | HLA-H | cis | multi-tissue | Pritchard |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:29664000-29690600 | Weak transcription | Right Atrium | heart |
2 | chr6:29670000-29670800 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
3 | chr6:29670200-29670800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
4 | chr6:29670200-29670800 | Enhancers | Liver | Liver |
5 | chr6:29670200-29671000 | Bivalent Enhancer | Primary B cells from peripheral blood | blood |
6 | chr6:29670200-29671000 | Bivalent Enhancer | Primary T cells fromperipheralblood | blood |
7 | chr6:29670200-29671000 | Bivalent Enhancer | Primary T helper cells PMA-I stimulated | -- |
8 | chr6:29670200-29678200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr6:29670400-29670800 | Enhancers | Primary T helper naive cells from peripheral blood | blood |
10 | chr6:29670400-29670800 | Bivalent Enhancer | Primary T helper 17 cells PMA-I stimulated | -- |
11 | chr6:29670400-29670800 | Bivalent Enhancer | Primary T regulatory cells fromperipheralblood | blood |
12 | chr6:29670400-29671000 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
13 | chr6:29670400-29671000 | Bivalent Enhancer | Skeletal Muscle Male | skeletal muscle |
14 | chr6:29670600-29670800 | Bivalent Enhancer | HUES64 Cell Line | embryonic stem cell |
15 | chr6:29670600-29670800 | Enhancers | Primary T helper naive cells fromperipheralblood | blood |
16 | chr6:29670600-29670800 | Enhancers | Primary T helper cells fromperipheralblood | blood |
17 | chr6:29670600-29670800 | Bivalent Enhancer | Adipose Nuclei | Adipose |
18 | chr6:29670600-29673200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |